The antifibrogenic effects of liposome-encapsulated IFN-α2b cream on skin wounds

Journal of Interferon and Cytokine Research

Volumn 19, Issue 12, 1999, Pages 1413-1419

  Takeuchi, Masaki ^a   Tredget, Edward E ^b   Scott, Paul G ^b   Kilani, Ruhangiz T ^b   Ghahary, Aziz ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; LIPOSOME; MESSENGER RNA; RECOMBINANT ALPHA2B INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CREAM; DRUG EFFECT; DRUG FORMULATION; DRUG SCREENING; EPITHELIZATION; FEMALE; GUINEA PIG; NONHUMAN; PRIORITY JOURNAL; PUNCH BIOPSY; SKIN INJURY;

ANIMALS; CICATRIX; DOSAGE FORMS; EXTRACELLULAR MATRIX; FEMALE; FIBROSIS; GUINEA PIGS; HYDROXYPROLINE; INTERFERON ALFA-2B; LIPOSOMES; PROCOLLAGEN; RNA, MESSENGER; SKIN;

EID: 0033403768     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099312876     Document Type: Article

References (22)

1. TREDGET, E.E., NEDELEC, B., SCOTT, P.G., GHAHARY, A. (1997). Hypertrophic scars, keloids and contractures: the cellular and molecular basis for therapy. Surg. Clin. North Am. 77, 701-730.
2. SU, C.W., ALIZADEH, K., BODDIE, A., LEE, R.C. (1998). The problem scar. Clin. Plast. Surg. 25, 451-465.
3. SEN, G.C., LENGYEL, P. (1992). The interferon system: a bird's eye view of its biochemistry. J. Biol. Chem. 267, 5017-5020.
4. GRANSTEIN, R.D., FLOTTE, T.J., AMENTO, E.P. (1990). Interferon and collagen production. J. Invest. Dermatol. 95, 75S-80S.
5. TREDGET, E.E., SHEN, Y.J., LIU, G., FORSYTH, N., SMITH, C., HARROP, A.R., SCOTT, P.O., GHAHARY, A. (1993). Regulation of collagen synthesis and messenger RNA levels in normal and hypertrophic scar fibroblasts in vitro by interferon alfa-2b. Wound Rep. Reg. 1, 156-165.
6. HARROP, A.R., GHAHARY, A., SCOTT, P.G., FORSYTH, R.T., UJI-ERIEDLAND, A., TREDGET, E.E. (1995). Regulation of collagen synthesis and mRNA expression in normal and hypertrophic scar fibroblasts in vitro by interferon-γ. J. Surg. Res. 58, 471-477.
7. GHAHARY, A., SHEN, Y.J., NEDELEC, B., SCOTT, P.G., TREDGET, E.E. (1995). Interferon gamma and alpha-2b differentially regulate the expression of collagenase and tissue inhibitor of metalloproteinase-1 messenger RNA in human hypertrophic and normal dermal fibroblasts. Wound Rep. Reg. 3, 176-84.
8. RODRIGUEZ-FRAGOSO, L., GONZALEZ, M.P., MURIEL, P. (1995). Interferon alpha 2b increases fibrolysis in fibrotic livers from bile duct ligated rats: possible participation of the plasminogen activator. Pharmacology 51, 341-346.
9. TREDGET, E.E., SHANKOWSKY, H.A., PANNU, R., NEDELEC, B., IWASHINA, T., GHAHARY, A., TAERUM, T.V., SCOTT, P.G. (1998). Transforming growth factor-β in thermally injured patients with hypertrophic scars: effects of interferon α-2b. Plast. Reconstr. Surg. 102, 1317-1328.
10. HERMAN, B., FLORES, F. (1997). Recurrence of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections. J. Am. Acad. Dermatol. 37, 755-757.
11. BERMAN, B., DUNCAN, M.R. (1989). Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro. J. Am. Acad. Dermal. 21, 694-702.
12. WEINER, N., WILLIAMS, N., BIRCH, G., RAMACHANDRN, C., SHIPMAN, C., JR., FLYNN, G. (1989). Topical delivery of liposomally encapsulated interferon evaluated in a cutaneous herpes guinea pig model. Antimicrob. Agents Chemother. 33, 1217-1221.
13. GHAHARY, A., SHEN, Q., ROGERS, J.A., WANG, R., FATHIAFSHAR, A., SCOTT, P.C., TREDGET, E.E. (1997). Liposome-associated interferon-α-2b functions as an anti-fibrogenic factor for human dermal fibroblasts. J. Invest. Dermatol. 109, 55-60.
14. EPPSTEIN, D.A., STEWART, W.E. (1981). Blinding and capture of human interferon-α by reverse evaporation vesicles, multilamellar vesicles, and small unilamellar vesicles. J. Interferon Res. 1, 495-504.
15. CHOMCZYNSKI, P., SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
16. TREDGET, E.E., FALK, N., SCOTT, P.C., HOGG, A.M., BURKE, J.F. (1990). Determination of 4-hydroxyproline in collagen by gas Chromatography/mass spectrometry. Anal. Biochem. 190, 259-265.
17. TELASKY, C.T., TREDGET, E.E., SHEN, Q., KHORRAMIZADEH, M.R., IWASHINA, T., SCOTT, P.G., GHAHARY, A. (1998). IFN-α-2b suppresses the fibrogenic effects of insulin-like growth factor-1 in dermal fibroblasts. J. Interferon Cytokine Res. 18, 571-577.
18. LARRABEE, W.F., JR., CHARLES, E.A., JAFFE, H.S., STEPHENSON, C., PETERSON, K.E. (1990). Intralesional interferon gamma treatment for keloids and hypertrophic scars. Arch. Otolaryngol. Head Neck Surg. 116, 1159-1162.
19. PITTET, B., RUBBIA-BRAUDT, L., DESMOULIERE, A., SAPPINO, A.-P., ROGGERO, P., GUERRET, S., GRIMAUD, J.-A., LACHER, R., MONTANDON, D., GABBIANI, G. (1994). Effect of γ-interferon on the clinical and biologic evolution of hypertrophic scars and Dupuytren's disease: an open pilot study. Plast. Reconstr. Surg. 93, 1224-1235.
20. SHORT, S.M., PAASCH, B.D., TURNER, J.H., WEINER, N., DAUGHERTY, A.L., RANDALL, J.M. (1996). Percutaneous absorption of biologically active interferon-gamma in a human skin graft-nude mouse model. Pharm. Res. 13, 1020-1027.
21. LADIN, D.A. (1998). Understanding dressing. Clin. Plast. Surg. 25, 433-441.
22. LAWRENCE, W.T. (1998). Physiology of the acute wound. Clin. Plast. Surg. 25, 321-340.